Add to Favourites
To login click here
The article discusses the use of artificial intelligence in the design of biopharmaceuticals, specifically focusing on identifying ideal neuropeptides for neurological treatments. The proposed framework, NPpred, utilizes a combination of genetic algorithms and deep learning to optimize the characteristics of these neuropeptides. An online application has also been developed for this purpose.
